PharmaPendium Content Release
News Date:
Wed, 14/07/2010
PharmaPendium is adding new content in the July content update.
FDA Approval Packages:
- 6 new drugs (Collagenase Clostridium Histolyticum, Dalfampridine, Ecallantide, Olanzapine Pamoate, Romidepsin, Velaglucerase Alfa)
- 2,116 new FDA Approval Documents, including documents for 75 Approval Packages
- 50,431 new pages of FDA Approval Documents
FDA Advisory Committee Meeting documents:
- 189,510 pages, 6,019 documents
EMA
- 64,045 pages 3,629 documents
(No EMA update in this release; 1 duplicate file removed)
Extracted Safety data observations:
- 17,139 new extracted data lines for FDA
AERS (post-marketing) reports:
- 355,187 new reports
This brings the new totals for PharmaPendium to the following:
- 1,376,262 pages of FDA Approval documents
- 57,900 FDA Approval documents
- 4,054 Drugs with data in PharmaPendium
- 996,780 extracted data lines in the Drug Safety database
- 3,300,129 AERS (post-marketing) reports
- 3,629 documents / 64,045 pages of EMA Approval documents
- 10,906 documents / 308,015 pages of FDA Classic Collection
- 8,581 documents / 332, 421 pages of FDA Advisory Committee Meeting documents
Watch our video to find out how.
